Cell and Gene Therapies – Trends, Supply Chain Challenges and Solutions, Upcoming Webinar Hosted by Xtalks
TORONTO (PRWEB) March 06, 2020 -- To control and direct the power of a patient’s immune system in order to fight disease is both ground-breaking as well as complicated. While the success of cell and gene therapy strives to become more mainstream and is increasingly the focus of researchers, the longer-term potential requires exploration. Researchers and manufacturers must translate the progress of cell and gene trials into broader programs targeting larger populations. Scalability and manufacturability are two challenges that the industry faces.
Nevertheless, before commercialization, cell and gene therapies encounter many other challenges as they progress towards their goal. The criticality and specialized handling needed for each shipment requires seamless execution of a vein-to-vein supply chain throughout the journey, and the manufacturers of these complex therapies must also consider the reliability, quality and cost effectiveness of any solution.
Join Darren Dasburg, Global Head of Cell Gene Services, Marken and Jeff Stone, Senior Director, Global Program Management, Marken in a live webinar on Thursday, March 19, 2020 at 9am EDT (1pm GMT).
For more information or to register for this event, visit Cell and Gene Therapies – Trends, Supply Chain Challenges and Solutions.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
ABOUT MARKEN
Marken is a wholly owned subsidiary of UPS. Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient and Home Health care services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 51 locations worldwide for clinical trial material storage and distribution. Marken’s more than 1,000 staff members manage 85,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry. http://www.marken.com
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Mira Nabulsi, Xtalks, http://www.xtalks.com, +1 (416) 977-6555 x 400, [email protected]
Share this article